Comparing Two Doses of Magnesium Sulphate to Control Blood Pressure During Laparoscopic Gallbladder Surgery.

A Comparative Study of Two Doses of Magnesium Sulphate for Attenuation of Pneumoperitoneum-Induced Hemodynamic Changes during Laparoscopic Cholecystectomy - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107928

Enrollment

Registered

2026-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K800- Calculus of gallbladder with acutecholecystitis Health Condition 2: K800- Calculus of gallbladder with acutecholecystitis

Interventions

Intervention1: magnesium dose 1: 30 mg/kg Control Intervention1: magnesium dose 2: 50mg/kg

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1 and ASA grade 2

Exclusion criteria

Exclusion criteria: 1.Known allergy to magnesium sulphate. 2.Severe renal dysfunction.

Design outcomes

Primary

Measure	Time frame
attenuation of haemodynamic changesTimepoint: 5 min,10 minutes,20 minutes,30 minutes,45 minutes,60 minutes,75 minutes,90 minutes,105 minutes,120 minutes	—

Secondary

Measure	Time frame
Bradycardia,hypotension.adverse effects like flushing,nauseaTimepoint: itntra operatively & post operativley till 120 minutes	—

Countries

India

Contacts

Public ContactDr Hemani Ahuja

Christian Medical College and Hospital ludhiana

mehrabgill19@gmail.com9888469906

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026